Akèy › Kansè gastro-intestinal › Texas › Houston
Etid klinik pou Kansè gastro-intestinal nan Houston, TX
21 etid pou Kansè gastro-intestinal ap chèche patisipan nan sit nan ak bò kote Houston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Ap rekriteFaz 2
- The University of Texas MD Anderson Cancer Center - Texas Medical Center, Houston
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Ap rekriteFaz 3
- Oncology Consultants P.A., Houston
- Oncology Consultants P.A., Houston
- Texas Oncology - Gulf Coast, Houston
- ak 7 plis
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
Ap rekriteFaz 3
- GSK Investigational Site, Houston
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Ap rekriteFaz 1/2
- MD Anderson, Houston
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Ap rekriteFaz 1/2
- Baylor College of Medicine, Houston
- The University of Texas MD Anderson Cancer Center, Houston
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Ap rekriteFaz 1/2
- The University of Texas, MD Anderson Cancer Center, Houston
A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)
Ap rekriteFaz 1/2
- GSK Investigational Site, Houston
Evaluation of Portal Vein Stenting in Patients With Portal Vein Stenosis and Gastrointestinal Cancers
Ap rekriteEtid obsèvasyon
- M D Anderson Cancer Center, Houston
Goals of Care Discussion for Patients With Advanced Lung and Gastrointestinal Cancer in the Emergency Department of a Comprehensive Cancer Center
Ap rekrite
- MD Anderson Cancer Center, Houston
A First in Human Study of PLT012 in Participants With Solid Tumor Cancers
Ap rekriteFaz 1
- MD Anderson Cancer Center, Houston
- NEXT Houston, Houston
Telephone Support in Advanced Gastrointestinal Cancer
Ap rekrite
- MD Anderson Cancer Center, Houston
Improving Comprehensive Care of Cancer Patients
Ap rekriteVolontè an sante akeyi
- Baylor College of Medicine, Houston
BOLSTER: Learning New Skills to Thrive
Ap rekrite
- The University of Texas MD Anderson Cancer Center, Houston
Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy
Ap rekriteEtid obsèvasyon
- M D Anderson Cancer Center, Houston
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Ap rekriteFaz 1
- University of Texas, MD Anderson Cancer Center, Houston
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Ap rekriteFaz 1/2
- MD Anderson Cancer Center, Houston
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Ap rekriteFaz 1/2
- The University of Texas MD Anderson Cancer Center, Houston
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Ap rekriteFaz 1/2
- MD Anderson Cancer Center, Houston
Molecular Epidemiology of Biliary Tree Cancers
Ap rekriteEtid obsèvasyon
- M D Anderson Cancer Center, Houston
Novel Rigidizing Overtube in Colonic Endoscopic Submucosal Dissection
Ap rekrite
- Baylor College of Medicine, Houston
- Baylor St. Lukes Medical Center (BSLMC), Houston
Traction vs. No Traction in Colonic ESD
Ap rekrite
- Baylor College of Medicine, Houston
- Baylor St. Lukes Medical Center (BSLMC), Houston
Etid Kansè gastro-intestinal nan lòt vil
- Boston, MA15 etid
- New York City, NY12 etid
- Nashville, TN10 etid
- Los Angeles, CA9 etid
- Dallas, TX8 etid
- Durham, NC8 etid
- Baltimore, MD8 etid
- Cincinnati, OH8 etid
- Arlington, VA8 etid
- San Antonio, TX7 etid
- Baldwin Park, CA7 etid
- Seattle, WA7 etid
Lòt etid nan Houston
- Kansè Poumon ki pa ti selil145 etid
- Kansè nan tete126 etid
- Kansè (tout kalite)121 etid
- Kansè Metastatik104 etid
- Kansè kolorektal102 etid
- Kansè ovè89 etid
- Leksemi mieloïd egi85 etid
- Kansè poumon78 etid
- Kansè pwostat76 etid
- Kansè Endomèt68 etid
- Kansè pankreyas61 etid
- Melanom59 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.